Immunotherapy Forum Video #22: Drs. Lauren Harshman and Sumanta (Monty) Pal answer questions from the audience following their presentations on immunotherapy for kidney cancer. Moderated by Dr. Marianne Davies.
Drugs in early stage clinical trials seem to show benefit for non-clear cell kidney cancer, but more trials must take place and patients are desperately needed to enroll in them.
Podcast: Play in new windowDownload
Among kidney cancer patients, the sub-type “non-clear cell” is the least common. As a result, not much research has been conducted on it.
Subscribe toGRACE Notes (Free Newsletter)
Mission | Disclaimer